Skip to content

Pharma Construct

Active
Private limited companyfounded 2022active for 4 yearsGrand'Route 43, 4590 Ouffet, BelgiumKBO/BCE: BE 0788.946.332
Summary

Pharma Construct has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€1,975) and a net result of -€983. Equity is shrinking by about 117% per year across the filed financial years. Its solvency ranks better than 5% of 4,274 sector peers (NACE 74, financial year 2025). The computed 12-month bankruptcy probability is 0.5% (low).

Overview

Activity
Other professional, scientific and technical activities
NACE 74999
1 site
Size
€425total assets 2025
Equity
-€1,975
Loss
-€983
Turnover not published (micro format)
Financial health
52 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
0.5%
Structure
Accounts 28 days early0 of 1 deed read
Why 52raises riskCapped at 59: negative equityNegative equity -€1,975Loss of €983, the second in a row (financial year 2025)lowers riskSector: Other professional, scientific and technical activities (NACE 74)Size: total assets €425Show the evidence

Checked score

Score 2025
52 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 7% of its sector peers (NACE 74, micro)
Negative equity caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Weak
Solvency 0=
equity -464.7% of total assets
Liquidity 16-34
short-term debt 564.7% · cash 12.6%
Profitability 0=
return on assets -231.4%
Bankruptcy probability, 12 months
0.5% Low
0%0.5%1.5%4%10%≥ 25%

About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (5,409 companies, NACE 74, micro)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025lowest value 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.4%▲ +0.2 percentage points vs 06-2025 08-2025: 0.4%● unchanged vs 07-2025 09-2025: 0.4%● unchanged vs 08-2025 10-2025: 0.4%● unchanged vs 09-2025 11-2025: 0.4%● unchanged vs 10-2025 12-2025: 0.4%● unchanged vs 11-2025 01-2026: 0.4%● unchanged vs 12-2025 02-2026: 0.4%● unchanged vs 01-2026 03-2026: 0.4%● unchanged vs 02-2026 04-2026: 0.3%▼ -0.1 percentage points vs 03-2026 05-2026: 0.4%▲ +0.1 percentage points vs 04-2026 06-2026: 0.4%● unchanged vs 05-2026 07-2026: 0.4%● unchanged vs 06-2026 08-2026: 0.5%▲ +0.1 percentage points vs 07-2026highest value 09-2026: 0.5%● unchanged vs 08-2026highest value 10-2026: 0.5%● unchanged vs 09-2026highest value
No credit on open account
balance sheet total too small for a liquidity verdict, and equity is negative.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 74, micro): better than 6% on solvency, 10% on liquidity, 7% on profitability and 5% on growth.

The bankruptcy probability was computed on 15-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Other professional, scientific and technical activities (NACE 74)
KBO
lowers risk · Size: total assets €425
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Negative equity -€1,975
NBB · annual accounts
raises risk · Loss of €983, the second in a row (financial year 2025)
NBB · annual accounts
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
22232425
2022 to 2025 · latest year -€1,975
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-07-2026, 28 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
28 days early
2024
37 days early
2023
42 days early
2022
7 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 25 days before the deadline; the sector median (NACE 74) for financial year 2024 is 3 days before the deadline, and 38% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 June (3 of the last 4 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
16-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2022.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Annual accounts filedfinancial year 2023 · micro…

Financials · financial year 2025, micro format

Equity
-€1,975▼ 99.2%
2024 · -€991
Total assets
€425▲ 61.5%
2024 · €263
Net result
-€983▲ 46.8%
2024 · -€1,848
Working capital
-€1,975▼ 99.2%
2024 · -€991
Trend over the years

2022 to 2025, 4 financial years

The operating result stays negative: a loss of €905 in 2025 against €1,771 in 2024; the loss shrinks.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result-€905 2025 Net result-€983 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 74, Other professional, scientific and technical activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital.

Every figure with its change against the financial year before
favourable unfavourable
Line2022202320242025
Operating result€2,340--€1,928-€1,771▲ 8.1%-€905▲ 48.9%
Net result€1,852within the sector's middle half--€1,996below the sector's middle half-€1,848below the sector's middle half▲ 7.4%-€983within the sector's middle half▲ 46.8%
Equity€2,852below the sector's middle half-€856below the sector's middle half▼ 70.0%-€991below the sector's middle half-€1,975below the sector's middle half▼ 99.2%
Total assets€4,569below the sector's middle half-€2,111below the sector's middle half▼ 53.8%€263below the sector's middle half▼ 87.5%€425below the sector's middle half▲ 61.5%
Debt€1,717-€1,254▼ 27.0%€1,254=€2,400▲ 91.3%
Working capital€2,852within the sector's middle half-€856within the sector's middle half▼ 70.0%-€991within the sector's middle half-€1,975below the sector's middle half▼ 99.2%
above within below the middle half of NACE 74, Other professional, scientific and technical activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Key figures and ratios
2025 value · change against 2024
Debt ≤ 1 year
€2,400▲
2024 · €1,254
Ratios withheld: a balance sheet total of €425 is too small for a meaningful ratio.
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 7,639 companies that looked in July 2024 the way this one looks now, 8.8% went bankrupt within 24 months and 84.8% are still going.

  • Micro
  • 2 to 5 years old
  • negative equity
  • a loss of 10% of the balance sheet or more
8.8% went bankrupt
5.6% stopped otherwise
84.8% still going

A further 0.7% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.5% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,474 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 7,639 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 23 lines
Balance sheet Code20242025
Assets
Total assets20/58€263€425▲
Current assets29/58€263€425▲
Amounts receivable within one year40/41€139€371▲
Other amounts receivable41€139€371▲
Cash at bank and in hand54/58€125€53▼
Equity and liabilities
Total equity and liabilities10/49€263€425▲
Equity10/15-€991-€1,975▼
Contributions10/11€1,000€1,000=
Profit (loss) carried forward14-€1,991-€2,975▼
Amounts payable17/49€1,254€2,400▲
Amounts payable within one year42/48€1,254€2,400▲
Trade debts44-€145
Suppliers440/4-€145
Other amounts payable47/48€1,254€2,254▲
Income statement Code20242025
Gross operating margin9900-€1,771-€905▲
Operating profit (loss)9901-€1,771-€905▲
Financial charges65/66B€77€78▲
Recurring financial charges65€77€78▲
Profit (loss) for the period before taxes9903-€1,848-€983▲
Profit (loss) for the period9904-€1,848-€983▲
Profit (loss) for the period to be appropriated9905-€1,848-€983▲
Appropriation of the result
Profit (loss) to be appropriated9906-€1,991-€2,975▼
Profit (loss) brought forward from the previous period14P-€144-€1,991▼

The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2022202320242025Change
Gross operating margin9900€2,340-€1,928-€1,771-€905▲ 48.9%
Operating profit (loss)9901€2,340-€1,928-€1,771-€905▲ 48.9%
Financial charges65/66B€25€67€77€78▲ 1.9%
Recurring financial charges65€25€67€77€78▲ 1.9%
Profit (loss) for the period before taxes9903€2,315-€1,996-€1,848-€983▲ 46.8%
Income taxes67/77€463----
Profit (loss) for the period9904€1,852-€1,996-€1,848-€983▲ 46.8%
Profit (loss) for the period to be appropriated9905€1,852-€1,996-€1,848-€983▲ 46.8%
Line2022202320242025Change
Assets
Total assets20/58€4,569€2,111€263€425▲ 61.5%
Current assets29/58€4,569€2,111€263€425▲ 61.5%
Amounts receivable within one year40/41€302€317€139€371▲ 168%
Other amounts receivable41€302€317€139€371▲ 168%
Cash at bank and in hand54/58€4,267€1,794€125€53▼ 57.1%
Equity and liabilities
Total equity and liabilities10/49€4,569€2,111€263€425▲ 61.5%
Equity10/15€2,852€856-€991-€1,975▼ 99.2%
Contributions10/11€1,000€1,000€1,000€1,000=
Profit (loss) carried forward14€1,852-€144-€1,991-€2,975▼ 49.4%
Amounts payable17/49€1,717€1,254€1,254€2,400▲ 91.3%
Amounts payable within one year42/48€1,717€1,254€1,254€2,400▲ 91.3%
Trade debts44---€145-
Suppliers440/4---€145-
Taxes, remuneration and social security45€463----
Taxes450/3€463----
Other amounts payable47/48€1,254€1,254€1,254€2,254▲ 79.7%
Line2022202320242025Change
Profit (loss) for the period9904€1,852-€1,996-€1,848-€983▲ 46.8%
Operating cash flow (approximation)€1,852-€1,996-€1,848-€983▲ 46.8%
Change in cash--€2,473-€1,669-€71▲ 95.7%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (4)
Financial year Type Filed Reference
31-12-2025 micro format 03-07-2026 2026-00252190
31-12-2024 micro format 24-06-2025 2025-00177752
31-12-2023 micro format 19-06-2024 2024-00141056
31-12-2022 micro format 07-08-2023 2023-00315805

Similar companies · same sector and region

This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of the 4,498 active companies whose main activity is other professional, scientific and technical activities (NACE 74999), figures are known for 1,982. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 0 of 1 Gazette act processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

On 27 July 2022, Pharma Construct was incorporated as a private limited company.1 The company has filed 4 sets of annual accounts, the latest for financial year 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
03-07
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
24-06
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
19-06
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial Weakest financial yearnet -€1,996
Net result drops to -€1,996, the lowest in the series; recovery starts the following year.
07-08
NBB filing Annual accounts filed
financial year 2022 · micro format · 7 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts

We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded27-07-2022
Financial year end31-12
Activities, NACEBEL 2025
74999Other professional, scientific and technical activities
68121Development of residential building projects
68122Development of non-residential building projects
70200Business and other management consultancy
E-invoicing
Reachable via Peppol
Peppol ID 0208:0788946332
Also 9925:BE0788946332
Registered 08-08-2022

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 16 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Check the withholding obligation If you pay this company for building or cleaning work, check before every payment whether you must withhold part of the invoice, with enterprise number 0788.946.332

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Ouffet · 1 establishment unit since 2022
registered office establishment The establishment unit on the map
Ground area
179 m²
Parcel 61075A0610/00W000, Wallonia. Linked by address, not a title deed.
3 companies at this address See who is registered here
1 establishment unit
Pharma Construct
Grand'Route 43, 4590 OuffetOther professional, scientific and technical activities
since 2022unit no. 2.334.230.863
1 parcel
Wallonia 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
61075A0610/00W000 Wallonia 179 m² - -
How the parcels are linked
Good to know
The parcel matches the address exactly.